(Q38756399)

6 September 2017

1 reference

title

Clinical decisions in the management of the cardiomyopathies (English)

1 reference

6 September 2017

Goodwin JF

1

1 reference

6 September 2017

publication date

1 December 1989

1 reference

6 September 2017

1 reference

6 September 2017

volume

38

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

988-999

1 reference

Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy

6 September 2017

cites work

1 reference

12 December 2020

Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis

1 reference

12 December 2020

Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study

1 reference

12 December 2020

Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy

1 reference

12 December 2020

Review of hypertrophic cardiomyopathy

1 reference

12 December 2020

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?

1 reference

12 December 2020

Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

1 reference

12 December 2020

[Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil]

1 reference

12 December 2020

Clinical features of fifteen patients with the hypereosinophilic syndrome

1 reference

12 December 2020

Treatment of myocarditis with OKT3 monoclonal antibody

1 reference

12 December 2020

Arrhythmias in Dilated and Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

12 December 2020

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

12 December 2020

New antiarrhythmic drugs

1 reference

12 December 2020

Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias

1 reference

12 December 2020

Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries

1 reference

12 December 2020

Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Long-term medical management of hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

1 reference

12 December 2020

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

12 December 2020

Interferon for treatment: the dust settles

1 reference

12 December 2020

Amiodarone for long-term management of patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

The frontiers of cardiomyopathy

1 reference

12 December 2020

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration

1 reference

12 December 2020

10.2165/00003495-198938060-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1032565051

0 references

1 reference